25.JPG)
Global Phage Therapy Market is expected to grow at an 20.50% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Phage therapy industry is experiencing huge research and development activities to develop products for different diseases and applications.The global phage therapy market is under development with no FDA-approved products. In the current scenario, natural phage-based products and compassionate phage therapy (CPT) are available in the market, which comprises current market revenue. Players such as Microgen (Russia), Duopharm (Germany), SES DERMA (Peru), BIOMED PERM NPO (Russia), and Phage Therapy Center are offering treatment for patients with chronic infectious diseases. However, the global phage therapy market has a tremendous opportunity to grow during the forecast period. By region, Europe dominates the market with a share of 57.0% of the global phage therapy market. Russia and Germany are the key markets holding the majority of the market for phage therapy in the region.
The market has reputed players across the globe with massive investment in clinical trials/ R&D activities. Clinical trial/product development companies in the market form strategic alliances with key pharmaceutical vendors to seek investment and tap potential markets in upcoming forecast years. Strategic alliances with contract manufacturers, the scientific community, and policymakers will enhance the development of phage therapy for clinical trials companies. The rapid increase in investment in the phage industry has been seen in recent years due to significant market opportunities in upcoming years.
The global phage therapy market is segmented on the basis of Distribution Channel, Route of Administration, Targeted Bacteria, Disease Indication and region. As per the Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By Route of Administration, the market is divided into Oral, Topical, Rectal Route, and Intravenous Route. According to the Targeted Bacteria, the market is segmented into Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, and Other Bacteria. The Disease Indication segment comprises Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, and Other Disease Indications. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 20.5% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025 to 2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Distribution Channel, Route of Administration, Targeted Bacteria, Disease Indication |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia; |
|
Competitive Landscape |
Armata Pharmaceuticals, Inc., BiomX (MBcure Ltd.), Eligo Bioscience, Intralytix, Inc., iNtODEWorld, Locus Biosciences, MicroPhage, Inc., TechnoPhage, Microgen Russia, Aumed, Aziya immunopreparat LLC, Sensei Biotherapeutics, Eliava BioPreparations, Nextbiotics, PhagePro, Nexabiome, Other Prominent Players |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Phage Therapy Market Snapshot
Chapter 4. Global Phage Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Route of Administration, Estimates & Trend Analysis
5.1. By Route of Administration, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Route of Administration:
5.2.1. Oral
5.2.2. Topical
5.2.3. Rectal Route
5.2.4. Intravenous Route
Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
6.1. By Distribution Channel & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
Chapter 7. Market Segmentation 3: By Targeted Bacteria Estimates & Trend Analysis
7.1. By Targeted Bacteria & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Targeted Bacteria:
7.2.1. Escherichia coli
7.2.2. Staphylococcus aureus
7.2.3. Streptococcus
7.2.4. Pseudomonas aeruginosa
7.2.5. Salmonella
7.2.6. Other Bacteria
Chapter 8. Market Segmentation 3: By Disease Indication Estimates & Trend Analysis
8.1. By Disease Indication & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
8.2.1. Urinary Tract Infections
8.2.2. Chronic Otitis
8.2.3. Dental Extraction
8.2.4. Chronic Ulcerative Colitis
8.2.5. Bone Infection
8.2.6. Wound and Skin Infections
8.2.7. Cystic Fibrosis
8.2.8. Other Disease Indications
Chapter 9. Phage Therapy Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2021-2034
9.1.2. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
9.1.3. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.1.4. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.1.5. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Phage Therapy Market revenue (US$ Million) By Route of Administration, 2021-2034
9.2.2. Europe Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2021-2034
9.2.3. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.2.4. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.2.5. Europe Phage Therapy Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Phage Therapy Market revenue (US$ Million) By Route of Administration, 2021-2034
9.3.2. Asia Pacific Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2021-2034
9.3.3. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.3.4. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.3.5. Asia Pacific Phage Therapy Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2021-2034
9.4.2. Latin America Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
9.4.3. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.4.4. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.4.5. Latin America Phage Therapy Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.5.4. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.5.5. Middle East & Africa Phage Therapy Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Armata Pharmaceuticals, Inc.
10.2.2. BiomX (MBcure Ltd.)
10.2.3. Eligo Bioscience
10.2.4. Intralytix, Inc.
10.2.5. iNtODEWorld
10.2.6. Locus Biosciences
10.2.7. MicroPhage, Inc.
10.2.8. TechnoPhage
10.2.9. Microgen Russia
10.2.10. Aumed
10.2.11. Aziya immunopreparat LLC
10.2.12. Sensei Biotherapeutics
10.2.13. Eliava BioPreparations
10.2.14. Nextbiotics
10.2.15. PhagePro,
10.2.16. Nexabiome
10.2.17. Other Prominent Players
Global Phage Therapy Market by Distribution Channel
Global Phage Therapy Market Based on Route of Administration
Global Phage Therapy Market Based on Targate Bacteria
Global Phage Therapy Market Based on Disease Indication
Global Phage Therapy Market Based on Region
Europe Revenue (US$ Mn) Forecast
North America
Asia Pacific
Latin America
Middle East & Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
